FDA probes abortion pill anew after court keeps mail access alive
A Louisiana court on April 7 asked the FDA to complete its internal review of mifepristone’s safety and gave the agency six months to provide the court with an update on the investigation.
FDA probes abortion pill anew after court keeps mail access alive Read More »
